Combining total metabolic syndrome score, MMP-1, and AST/ALT ratio might detect ≥F2 in MASH with higher diagnostic accuracy than other NITs and MRE. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.